Fasting insulin: difference between revisions
Diff·revision 18 → 19·13:46, 8 Aug 2025
Difference between revision 18 and revision 19 of Fasting insulin. 3 lines changed; the page grew by 288 bytes.
| Revision 18 — 03:35, 10 Jul 2025 SchemaSorcha (talk) add the units and the conversion factor to SI 3,910 bytes ±0 | Revision 19 — 13:46, 8 Aug 2025 BaselineBex (talk) expand §Why it needs glucose alongside it 4,198 bytes +288 | ||
|---|---|---|---|
| 37 | Under incretin therapy the picture is mixed: secretion is amplified while the drug is present, and sensitivity improves with weight loss, so fasting insulin reflects both influences. Attributing a change to either alone is unsound.{{r|wallace2004}} | 37 | Under incretin therapy the picture is mixed: secretion is amplified while the drug is present, and sensitivity improves with weight loss, so fasting insulin reflects both influences. Attributing a change to either alone is unsound.{{r|wallace2004}} |
| 38 | 38 | ||
| + | 39 | Fasting insulin appears on many of the panels discussed in this field; see [[Baseline laboratory panel]]. Nothing on this wiki is medical advice.{{r|ada2024}} | |
| + | 40 | ||
| 39 | == References == | 41 | == References == |
| 40 | {{reflist}} | 42 | {{reflist}} |
| ⋮ | ⋮ | ||
| 42 | <ref name="matthews1985">Matthews DR, Hosker JP, Rudenski AS, et al. "Homeostasis model assessment." ''Diabetologia'' 28(7):412–419 (1985). PMID 3899825.</ref> | 44 | <ref name="matthews1985">Matthews DR, Hosker JP, Rudenski AS, et al. "Homeostasis model assessment." ''Diabetologia'' 28(7):412–419 (1985). PMID 3899825.</ref> |
| 43 | <ref name="drucker2018">Drucker DJ. "Mechanisms of action and therapeutic application of glucagon-like peptide-1." ''Cell Metabolism'' 27(4):740–756 (2018). PMID 29617641.</ref> | 45 | <ref name="drucker2018">Drucker DJ. "Mechanisms of action and therapeutic application of glucagon-like peptide-1." ''Cell Metabolism'' 27(4):740–756 (2018). PMID 29617641.</ref> |
| + | 46 | <ref name="ada2024">American Diabetes Association. "Standards of Care in Diabetes." ''Diabetes Care'' 47(Suppl 1) (2024).</ref> | |
| 44 | 47 | ||
| 45 | == See also == | 48 | == See also == |